Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Noto

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
The Journal of Clinical Investigation|September 20, 2011
Loss of memory B cells during chronic HIV infection is driven by Foxo3a- and TRAIL-mediated apoptosisJulien van Grevenynghe, Rafael A Cubas, Alessandra Noto, et al.
Nature Medicine|March 9, 2010
Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infectionElias A Said, Franck P Dupuy, Lydie Trautmann, et al.
Cell Reports|October 2, 2021
A highly potent antibody effective against SARS-CoV-2 variants of concernCraig Fenwick, Priscilla Turelli, Laurent Perez, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
The Journal of Clinical Investigation|September 20, 2011
Loss of memory B cells during chronic HIV infection is driven by Foxo3a- and TRAIL-mediated apoptosisJulien van Grevenynghe, Rafael A Cubas, Alessandra Noto, et al.
Nature Medicine|March 9, 2010
Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infectionElias A Said, Franck P Dupuy, Lydie Trautmann, et al.
Cell Reports|October 2, 2021
A highly potent antibody effective against SARS-CoV-2 variants of concernCraig Fenwick, Priscilla Turelli, Laurent Perez, et al.
Pageof 3